In:
Journal of Cutaneous Pathology, Wiley, Vol. 50, No. 7 ( 2023-07), p. 619-622
Abstract:
In addition to melanoma, a large and diverse family of tumors shows melanocytic differentiation. The best characterized member of this family is clear cell sarcoma, which is characterized by EWSR1::ATF1 and EWSR1::CREB1 fusions. These fusions drive the transcription of MITF , the master regulator of melanocytic differentiation. Clear cell tumor with melanocytic differentiation and MITF::CREM translocation is a recently described tumor with some similarities to clear cell sarcoma. However, only a single case has been reported. Here, we describe a second molecularly proven case that arose on the scalp of a newborn baby. In contrast to the prior reported case, the current case showed predominantly high‐grade cytomorphologic features with only focal clear cell areas. Similar to the prior case, the tumor showed immunohistochemical evidence of neural crest origin/differentiation with prominent melanocytic differentiation. The fusion breakpoints were also similar and preserved the transcriptional activation domain of CREM, suggesting that CREM hyperactivity is a major feature of this tumor type. The current tumor showed a short‐interval recurrence. These results expand the clinical and pathologic spectrum of this potentially new entity.
Type of Medium:
Online Resource
ISSN:
0303-6987
,
1600-0560
Language:
English
Publisher:
Wiley
Publication Date:
2023
detail.hit.zdb_id:
2018100-0
